Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China flag China · Delayed Price · Currency is CNY
20.24
+0.02 (0.10%)
Mar 30, 2026, 4:00 PM EDT

Jiangsu CoWin Biotech Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-157.21-84.41159.26125.85
Depreciation & Amortization
38.8333.5523.2515.73
Other Amortization
4.333.693.062.31
Loss (Gain) From Sale of Assets
-0.19-1.240.51-1.29
Asset Writedown & Restructuring Costs
3.444.270.060.03
Loss (Gain) From Sale of Investments
-18.21-26.71-7.94-7.57
Provision & Write-off of Bad Debts
21.6720.89.511.6
Other Operating Activities
3.838.9416.853.13
Change in Accounts Receivable
-11.8452.74-97.15-16.08
Change in Inventory
-19.4817.55-23.29-9.6
Change in Accounts Payable
21.91-43.7514.1820.47
Change in Other Net Operating Assets
2.916.3313.158.43
Operating Cash Flow
-113.26-11.72107.37144.5
Operating Cash Flow Growth
---25.70%32.70%
Capital Expenditures
-48.41-159.22-100.38-124.39
Sale of Property, Plant & Equipment
0.21.010.010.08
Cash Acquisitions
-13.83--5.21-
Investment in Securities
121.31-479-16568.6
Other Investing Activities
14.8916.296.778.71
Investing Cash Flow
74.16-620.91-263.81-47
Long-Term Debt Issued
6---
Long-Term Debt Repaid
-14.4-7.57-5.31-4.54
Net Debt Issued (Repaid)
-8.4-7.57-5.31-4.54
Issuance of Common Stock
3.06-1,083-
Repurchase of Common Stock
-43.66---
Common Dividends Paid
-3.9-50.73--
Other Financing Activities
-6-19.27-3.22
Financing Cash Flow
-52.9-52.31,058-7.76
Foreign Exchange Rate Adjustments
0.210.641.79-0.77
Net Cash Flow
-91.79-684.29903.7288.98
Free Cash Flow
-161.67-170.946.9920.11
Free Cash Flow Growth
---65.25%-78.93%
Free Cash Flow Margin
-128.44%-99.77%1.34%5.94%
Free Cash Flow Per Share
-1.45-1.520.070.24
Cash Income Tax Paid
5.6623.4536.7217.62
Levered Free Cash Flow
-127.04-115.19-38.17-9.99
Unlevered Free Cash Flow
-126.16-114.13-36.96-8.79
Change in Working Capital
-9.7529.39-97.194.71
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.